DVL2 and cholangiocarcinoma: Further studies reveal that the RBM10C761Y mutation led to an increase in ASPM203 RNA and protein levels, and the elevated ASPM203 stabilized DVL2 protein, upregulated the Wnt/β-catenin pathway, and promoted CCA cell progression.